TOCILIZUMAB IN POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS - A COST-UTILITY MODEL FOR THE UNITED KINGDOM

被引：1
|
作者：
Chang, S. [1 ]
Sawyer, L. [1 ]
Dejonckheere, F. [2 ]
van Suijlekom-Smit, L. W. [3 ]
Anink, J. [3 ]
Diamantopoulos, A. [1 ]
机构：
[1] Symmetron Ltd, Elstree, England
[2] F Hoffmann La Roche Ltd, Basel, Switzerland
[3] Erasmus MC Sophia Childrens Hosp, Rotterdam, Netherlands
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1496
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A564 / A564
页数：1
相关论文
共 50 条
  • [1] COST-UTILITY OF TOCILIZUMAB IN THE TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN FINLAND
    Hallinen, T.
    Soini, E. J.
    Diamantopoulos, A.
    Dejonckheere, F.
    Vihervaara, V.
    Hautala, A.
    Aalto, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 258 - 259
  • [2] COST-UTILITY ANALYSIS OF TOCILIZUMAB IN THE TREATMENT OF ACTIVE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
    Vicente, C.
    Sabapathy, S.
    Formica, L.
    Maturi, B.
    Piwko, C.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A225 - A225
  • [3] Radiological improvement by tocilizumab in polyarticular juvenile idiopathic arthritis
    Tozawa, Yusuke
    Fujita, Shouji
    Abe, Shuji
    Kitamura, Koichi
    Kobayashi, Ichiro
    [J]. PEDIATRICS INTERNATIONAL, 2015, 57 (02) : 307 - 310
  • [4] Cost-utility and budget impact analysis of tocilizumab for the treatment of refractory systemic juvenile idiopathic arthritis in Thailand
    Kittiratchakool, Nitichen
    Kulpokin, Disorn
    Chanjam, Chonticha
    Vilaiyuk, Soamarat
    Charuvanij, Sirirat
    Phongsamart, Gun
    Khaosut, Parichat
    Tanya, Manasita
    Nanagara, Ratanavadee
    Nantapaisarn, Sira
    Leelahavarong, Pattara
    [J]. BMJ OPEN, 2020, 10 (09):
  • [5] TOCILIZUMAB IN METHOTREXATE-INTOLERANT OR CONTRAINDICATED PATIENTS-A COST-UTILITY MODEL FOR THE UNITED KINGDOM
    Harland, Dave
    Gibbons, Carl
    Pang, Hok
    Huertas, Catherine
    Diamantopoulos, Alex
    Dejonckheere, Fred
    [J]. RHEUMATOLOGY, 2013, 52 : 84 - 84
  • [6] COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB SC IN POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS (PJIA) TREATMENT IN TURKEY
    Erdogan-Ciftci, E.
    Yanik, L.
    Saka, O.
    [J]. VALUE IN HEALTH, 2019, 22 : S699 - S700
  • [7] COST-UTILITY OF RHEUMATOID ARTHRITIS MONOTHERAPY WITH TOCILIZUMAB IN SPAIN
    Benito Ruiz, P.
    Navarro Sarabia, F.
    Gomez Reino, J.
    Poveda, J.
    Alvaro Gracia, J.
    Rubio-Rodriguez, D.
    Ruiz-Beato, E.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A565 - A565
  • [8] TOCILIZUMAB IN METHOTREXATE-NAIVE RHEUMATOID ARTHRITIS - A COST-UTILITY MODEL FOR SLOVAKIA
    Chang, S.
    Sawyer, L.
    Dejonckheere, F.
    Grichova, L.
    Diamantopoulos, A.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A648 - A648
  • [9] SAFETY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH SYSTEMIC AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
    Ramanan, Athimalaipet V.
    Brunner, Hermine I.
    Ruperto, Nicola
    Martini, Alberto
    Cuttica, Ruben J.
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Horneff, Gerd
    Gamir-Gamir, Maria Luz
    Hufnagel, Markus
    Douglass, Wendy
    Wells, Chris
    Wimalasundera, Sunethra
    Mallalieu, Navita L.
    Lovell, Daniel J.
    De Benedetti, Fabrizio
    [J]. RHEUMATOLOGY, 2019, 58
  • [10] Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis
    Ruperto, Nicolino
    Brunner, Hermine, I
    Ramanan, Athimalaipet, V
    Horneff, Gerd
    Cuttica, Ruben
    Henrickson, Michael
    Anton, Jordi
    Lucica Boteanu, Alina
    Calvo Penades, Inmaculada
    Minden, Kirsten
    Schmeling, Heinrike
    Hufnagel, Markus
    Weiss, Jennifer E.
    Pardeo, Manuela
    Nanda, Kabita
    Roth, Johannes
    Rubio-Perez, Nadina
    Hsu, Joy C.
    Wimalasundera, Sunethra
    Wells, Chris
    Bharucha, Kamal
    Douglass, Wendy
    Bao, Min
    Mallalieu, Navita L.
    Martini, Alberto
    Lovell, Daniel
    De Benedetti, Fabrizio
    [J]. RHEUMATOLOGY, 2021, 60 (10) : 4568 - 4580
12345